Search Results - "Safi Jr, Jorge"
-
1
Inhibition of IL‐17A by secukinumab shows no evidence of increased Mycobacterium tuberculosis infections
Published in Clinical & translational immunology (25-08-2017)“…Secukinumab, a fully human monoclonal antibody that selectively neutralizes interleukin‐17A (IL‐17A), has been shown to have significant efficacy in the…”
Get full text
Journal Article -
2
Incidence of Uveitis in Secukinumab‐treated Patients With Ankylosing Spondylitis: Pooled Data Analysis From Three Phase 3 Studies
Published in ACR open rheumatology (01-05-2020)“…Objective The objective of this study was to report the incidence of uveitis in secukinumab‐treated patients with ankylosing spondylitis (AS) in a pooled…”
Get full text
Journal Article -
3
Secukinumab Immunogenicity over 52 Weeks in Patients with Psoriatic Arthritis and Ankylosing Spondylitis
Published in Journal of rheumatology (01-04-2020)“…Secukinumab, a fully human antiinterleukin 17A monoclonal antibody, is efficacious for the treatment of psoriatic arthritis (PsA) and ankylosing spondylitis…”
Get full text
Journal Article -
4
A Multicentre, Prospective Study to Evaluate Costs of Septic Patients in Brazilian Intensive Care Units
Published in PharmacoEconomics (01-01-2008)“…Background Sepsis has a high prevalence within intensive care units, with elevated rates of morbidity and mortality, and high costs. Data on sepsis costs are…”
Get full text
Journal Article -
5
Gene Therapy with Angiogenic Factors: A New Potential Approach to the Treatment of Ischemic Diseases
Published in Journal of Molecular and Cellular Cardiology (01-09-1997)Get full text
Book Review Journal Article -
6
Late Failure of Surgical Treatment for Bioprosthetic Valve Endocarditis Due to Candida tropicalis
Published in Clinical infectious diseases (01-02-1996)“…We report a case of Candida tropicalis endocarditis in a patient who was not an intravenous drug user; this patient had a probable relapse 44 months after…”
Get full text
Journal Article